These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20799139)

  • 21. Access to medicines report cards.
    Mullard A
    Nat Rev Drug Discov; 2016 Nov; 15(12):811. PubMed ID: 27895336
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug shortage--cause and prevention].
    Madsen S; Claesson U; Wesenberg GR; Endresen M; Walter AB
    Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2154-5. PubMed ID: 23076482
    [No Abstract]   [Full Text] [Related]  

  • 23. Outsourcing drug discovery to India and China: from surviving to thriving.
    Subramaniam S; Dugar S
    Drug Discov Today; 2012 Oct; 17(19-20):1055-8. PubMed ID: 22542471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competition And Vulnerabilities In The Global Supply Chain For US Generic Active Pharmaceutical Ingredients.
    Socal MP; Ahn K; Greene JA; Anderson GF
    Health Aff (Millwood); 2023 Mar; 42(3):407-415. PubMed ID: 36791331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transparency throughout the production chain--a way to reduce pollution from the manufacturing of pharmaceuticals?
    Joakim Larsson DG; Fick J
    Regul Toxicol Pharmacol; 2009 Apr; 53(3):161-3. PubMed ID: 19545507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trials in India.
    Maiti R; M R
    Pharmacol Res; 2007 Jul; 56(1):1-10. PubMed ID: 17391981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers in Clinical Trials--SMi Conference. 23-24 September 2009, London, UK.
    Walker G
    IDrugs; 2009 Nov; 12(11):673-4. PubMed ID: 19844848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Inhaled Products - Joint Pharmaceutical Analysis Group Meeting.
    Chamberlain J
    IDrugs; 2009 Dec; 12(12):747-9. PubMed ID: 19943214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can China bring its own pipeline to the market?
    Louët S
    Nat Biotechnol; 2004 Dec; 22(12):1497-9. PubMed ID: 15583646
    [No Abstract]   [Full Text] [Related]  

  • 30. Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing.
    Jiang S; Chen Z; Wu T; Wang H
    J Glob Health; 2020 Jun; 10(1):010314. PubMed ID: 32566150
    [No Abstract]   [Full Text] [Related]  

  • 31. Biotech products pose distribution challenges.
    Szeinbach SL; Gillenwater EL
    Am Pharm; 1994 Mar; NS34(3):19-20. PubMed ID: 8192094
    [No Abstract]   [Full Text] [Related]  

  • 32. Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs).
    Elder DP; Lipczynski AM; Teasdale A
    J Pharm Biomed Anal; 2008 Nov; 48(3):497-507. PubMed ID: 18657926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The quiet revolution: outsourcing in pharma.
    Crossley R
    Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
    [No Abstract]   [Full Text] [Related]  

  • 34. More drugs, less protection.
    Nature; 2002 Sep; 419(6904):233. PubMed ID: 12239521
    [No Abstract]   [Full Text] [Related]  

  • 35. An audience with...Sir John Sulston.
    Sulston J
    Nat Rev Drug Discov; 2005 Feb; 4(2):98. PubMed ID: 15756755
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of quality, capacity, and productivity at Merck.
    Nathan J; Venkataraman R
    Hosp Mater Manage Q; 1999 Feb; 20(3):64-9. PubMed ID: 10345635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 38. Global health challenges in the pharmaceutical world.
    Abraham J
    Health Econ Policy Law; 2009 Jan; 4(Pt 1):115-27. PubMed ID: 19099620
    [No Abstract]   [Full Text] [Related]  

  • 39. Rationale drug therapy: reasons for failure and suggestions for its implementation.
    Mathur GP; Kushwaha KP; Mathur S
    Indian Pediatr; 1993 Jun; 30(6):815-8. PubMed ID: 7726879
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug studies in developing countries.
    Olliaro PL; Vijayan R; Inbasegaran K; Lang CC; Looareesuwan S
    Bull World Health Organ; 2001; 79(9):894-5. PubMed ID: 11584742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.